메뉴 건너뛰기




Volumn 6, Issue SUPPL. 3, 2003, Pages 49-54

Drospirenone: A new cardiovascular-active progestin with antialdosterone and antiandrogenic properties

Author keywords

Amenorrhea; Antialdosterone; Antiandrogenic; Cardiovascular disease; Drospirenone; Hypertension; Postmenopausal symptoms

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANDROGEN; ANTIANDROGEN; CARDIOVASCULAR AGENT; CYPROTERONE ACETATE; DIENOGEST; DIURETIC AGENT; DROSPIRENONE PLUS ESTRADIOL; DRUG RECEPTOR; ESTROGEN; GESTAGEN; GLUCOCORTICOID; GLUCOCORTICOID ANTAGONIST; HORMONE; LEVONORGESTREL; LIPID; MEDROXYPROGESTERONE ACETATE; MINERALOCORTICOID; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; NORETHISTERONE; NORGESTIMATE; PROGESTERONE; SPIRONOLACTONE; TRIMEGESTONE;

EID: 1642538423     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (46)

References (12)
  • 1
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
    • (2002) J Am Med Assoc , vol.288 , pp. 321-333
  • 2
    • 1642538421 scopus 로고    scopus 로고
    • Hormone therapy and the cardiovascular system: The critical role of progestins
    • Sitruk-Ware R. Hormone therapy and the cardiovascular system: the critical role of progestins. Climacteric 2003;6(Suppl 3):21-8
    • (2003) Climacteric , vol.6 , Issue.3 SUPPL. , pp. 21-28
    • Sitruk-Ware, R.1
  • 5
    • 0012456580 scopus 로고    scopus 로고
    • Tripos Inc., E. Eckie
    • Sybyl Version 6.6, Tripos Inc., E. Eckie, 2000
    • (2000) Sybyl Version 6.6
  • 6
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • RALES investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17
    • (1999) N Engl J Med , vol.341 , pp. 709-717
  • 7
    • 0035818917 scopus 로고    scopus 로고
    • Aldosterone in congestive heart failure
    • Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345:1689-97
    • (2001) N Engl J Med , vol.345 , pp. 1689-1697
    • Weber, K.T.1
  • 8
    • 1642538427 scopus 로고    scopus 로고
    • Cardiovascular benefits of aldosterone receptor antagonists
    • Williams GH. Cardiovascular benefits of aldosterone receptor antagonists. Climacteric 2003;6(Suppl 3):29-35
    • (2003) Climacteric , vol.6 , Issue.3 SUPPL. , pp. 29-35
    • Williams, G.H.1
  • 9
    • 1642578956 scopus 로고    scopus 로고
    • Potassium: More beneficial effects
    • He FJ, MacGregor GA. Potassium: more beneficial effects. Climacteric 2003;6(Suppl 3):36-48
    • (2003) Climacteric , vol.6 , Issue.3 SUPPL. , pp. 36-48
    • He, F.J.1    MacGregor, G.A.2
  • 10
    • 0342593411 scopus 로고
    • Women's heart research: It's about time
    • Wenger NK. Women's heart research: it's about time. J Women Health 1995;4:459-60
    • (1995) J Women Health , vol.4 , pp. 459-460
    • Wenger, N.K.1
  • 11
    • 0030002580 scopus 로고    scopus 로고
    • The progression from hypertension to congestive heart failure
    • Levy D, Larson ME, Vosan RS, et al. The progression from hypertension to congestive heart failure. J Am Med Assoc 1996;275:1557-62
    • (1996) J Am Med Assoc , vol.275 , pp. 1557-1562
    • Levy, D.1    Larson, M.E.2    Vosan, R.S.3
  • 12
    • 0004312698 scopus 로고    scopus 로고
    • Dallas, Texas: American Heart Association
    • American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association, 2001
    • (2001) 2002 Heart and Stroke Statistical Update


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.